Sight Sciences' newest MIGS device gains FDA clearance for single-pass canaloplasty and trabeculotomy in open-angle glaucoma.

New system expands the Company’s leadership in interventional glaucoma with the first FDA cleared MIGS device for single pass canaloplasty with TruSync™ Plus innovation.

Sight Sciences’ OMNI Ultra receives US FDA 510(k) clearance for canaloplasty; plans US commercial launch in fourth quarter of 2026: Menlo Park, California Thursday, August 6, 20 ...

Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company, today announced U.S. Food and Drug Administration (FDA) ...

A look at a MiG-23 inside a hangar, with commentary and reactions around the aircraft and what makes the scene stand out. A ...

How does minimally invasive glaucoma surgery help patients manage glaucoma earlier and with fewer medications?

From soft launches to major development hubs, Canada has become an increasingly important part of the North American games ...

Your team spent three months writing production-grade inference code. The model is tuned. The pipeline is tested. The ...

Built in 1954 and capable of speeds exceeding 540 mph (870 km/h), the Soviet MiG-15 became one of the most influential fighter jets in aviation history. Famous for its role during the Korean War, this ...

On the morning of August 15, the Defense Forces used FP-5 Flamingo missiles to hit the Progress Rocket and Space Center (TsKB ...

Bhawana Kanth has made history by completing the prestigious 'Fighter Combat Leader' (FCL) course at the 'Tactics and Air Combat Development Establishment' (TACDE) in Gwalior. The FCL is often called ...

France has reportedly submitted its detailed technical and commercial proposal to India for the acquisition of 114 Rafale ...